Response to "Tocilizumab therapy and COVID-19"

J Osteopath Med. 2021 Sep 8;121(11):867-868. doi: 10.1515/jom-2021-0212.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab